The DOI matches its Crossref record; 434 of the 434 references it cites were found in a registry or an index.
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases
Open accessAbstract
The chemokine receptors CXCR1/2 and their ligand CXCL8 are essential for the activation and trafficking of inflammatory mediators as well as tumor progression and metastasis. The CXCL8-CXCR1/2 signaling axis is involved in the pathogenesis of several diseases including chronic obstructive pulmonary diseases (COPD), asthma, cystic fibrosis and cancer. Interaction between CXCL8 secreted by select cancer cells and CXCR1/2 in the tumor microenvironment is critical for cancer progression and metastasis. The CXCL8-CXCR1/2 axis may play an important role in tumor progression and metastasis by regulating cancer stem cell (CSC) proliferation and self-renewal. During the past two decades, several small-molecule CXCR1/2 inhibitors, CXCL8 releasing inhibitors, and neutralizing antibodies against CXCL8 and CXCR1/2 have been reported. As single agents, such inhibitors are expected to be efficacious in various inflammatory diseases. Several preclinical studies suggest that combination of CXCR1/2 inhibitors along with other targeted therapies, chemotherapies, and immunotherapy may be effective in treating select cancers. Currently, several of these inhibitors are in advanced clinical trials for COPD, asthma, and metastatic breast cancer. In this review, we provide a comprehensive analysis of the role of the CXCL8-CXCR1/2 axis and select genes co-expressed in this pathway in disease progression. We also discuss the latest progress in developing small-molecule drugs targeting this pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 434
Qiu, Y., Zhu, J., Bandi, V., Guntupalli, K. K., & Jeffery, P. K. (2007) · Thorax · doi:10.1136/thx.2006.066670 · Cited by 122
Transcription of Interleukin-8: How Altered Regulation Can Affect Cystic Fibrosis Lung Disease
Jundi, K., & Greene, C. M. (2015) · Biomolecules · doi:10.3390/biom5031386 · Cited by 122
Fan, G.-H., Yang, W., Wang, X.-J., Qian, Q., & Richmond, A. J. (2000) · Biochemistry · doi:10.1021/bi001661b · Cited by 122
Lv, M., Xu, Y., Tang, R., Ren, J., Shen, S., Chen, Y., Liu, B., Hou, Y., & Wang, T. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0448 · Cited by 121
Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
Werner, L., Guzner‐Gur, H., & Dotan, I. (2013) · Theranostics · doi:10.7150/thno.5135 · Cited by 121
Wang, L., Zhao, X.-C., Cui, W., Ma, Y.-Q., Ren, H.-L., Zhou, X., Fassett, J., Yang, Y.-Z., Chen, Y., Xia, Y.-L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020754 · Cited by 121
Dwyer, M. P., Yu, Y., Chao, J., Aki, C., Chao, J., Biju, P., GIRIJAVALLABHAN, V. M., Rindgen, D., Bond, R. W., Mayer-Ezel, R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609622 · Cited by 120
Tang, H., Sun, Y., Shi, Z., Huang, H., Fang, Z., Chen, J., Xiu, Q., & Li, B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201827 · Cited by 120
Wu, F.-J., Zhao, Y., Jiao, T., Shi, D.-Y., Zhu, X., Zhang, M., Shi, M., & Zhou, H. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0316-6 · Cited by 119
Agarwal, A., Tressel, S. L., Kaimal, R., Balla, M., Lam, F. H., Covic, L., & Kuliopulos, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4341 · Cited by 119
Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung Carcinoma
Yanagawa, J., Walser, T. C., Zhu, L. X., Hong, L., Fishbein, M. C., Mah, V. H., Chia, D., Goodglick, L., Elashoff, D. A., Luo, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1558 · Cited by 119
MacManus, C. F., Pettigrew, J., Seaton, A., Wilson, C., Maxwell, P. J., Berlingeri, S., Purcell, C., McGurk, M., Johnston, P. G., & Waugh, D. J. J. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0032 · Cited by 118
Yang, W., Wang, D., & Richmond, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11328 · Cited by 117
Sharma, B., Nawandar, D. M., Nannuru, K. C., Varney, M. L., & Singh, R. K. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0529 · Cited by 116
Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD
Kvedaraite, E., Lourda, M., Ideström, M., Chen, P., Olsson‐Åkefeldt, S., Forkel, M., Gavhed, D., Lindforss, U., Mjösberg, J., Henter, J., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-309014 · Cited by 115
Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder
Clunes, M. T., & Boucher, R. C. (2007) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2007.09.001 · Cited by 115
Reiland, J., Furcht, L. T., & McCarthy, J. B. (1999) · The Prostate · Cited by 115
A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis
Soyza, A. D., Pavord, I. D., Elborn, J. S., Smith, D., Wray, H., Puu, M., LARSSON, B. S., & Stockley, R. A. (2015) · European Respiratory Journal · doi:10.1183/13993003.00148-2015 · Cited by 114
The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma
Grépin, R., Guyot, M., Giuliano, S., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1267 · Cited by 114
L'Heureux, G., Bourgoin, S. G., Jean, N., et al. (1995) · Blood · doi:10.1182/blood.v85.2.522.522 · Cited by 113
Souza, D. G., Bertini, R., Vieira, A. T., Cunha, F. Q., Poole, S., Allegretti, M., Colotta, F., & Teixeira, M. M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705862 · Cited by 113
Moss, R. B., Mistry, S. J., Konstan, M. W., Pilewski, J. M., Kerem, E., Tal‐Singer, R., & Lazaar, A. L. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.08.016 · Cited by 113
Grespan, R., Fukada, S. Y., Lemos, H. D. P., Vieira, S. M., Napimoga, M. H., Teixeira, M. M., Fraser, A. R., Liew, F. Y., McInnes, I. B., & Cunha, F. Q. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23597 · Cited by 110
Sukkurwala, A. Q., Martins, I., Wang, Y., Schlemmer, F., Ruckenstuhl, C., Durchschlag, M., Michaud, M., Senovilla, L., Sistigu, A., Ma, Y., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.73 · Cited by 109
The CXC Receptor 2 Is Overexpressed in Psoriatic Epidermis
Kulke, R., Bornscheuer, E., Schlüter, C., Bartels, J., Röwert, J., Sticherling, M., & Christophers, E. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00074.x · Cited by 108
Osawa, Y., Nagaki, M., Banno, Y., Brenner, D. A., Asano, T., Nozawa, Y., Moriwaki, H., & Nakashima, S. (2002) · Infection and Immunity · doi:10.1128/iai.70.11.6294-6301.2002 · Cited by 108
Tazzyman, S. J., Barry, S. T., Ashton, S. E., Wood, P. J., Blakey, D. C., Lewis, C. E., & Murdoch, C. (2011) · International Journal of Cancer · doi:10.1002/ijc.25987 · Cited by 107
Impact of isoflurane on malignant capability of ovarian cancer in vitro
Luo, X., Zhao, H., Hennah, L., Ning, J., Liu, J., Tu, H., & Ma, D. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu408 · Cited by 107
Kuboki, S., Shin, T., Huber, N., Eismann, T., Galloway, E., Schuster, R. M., Blanchard, J. A., Edwards, M. J., & Lentsch, A. B. (2008) · Hepatology · doi:10.1002/hep.22471 · Cited by 105
Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis.
Izzo, R. S., Witkon, K., Chen, A. I., Hadjiyane, C., Weinstein, M. I., & Pellecchia, C. (1992) · PubMed · Cited by 104
Li, L., Xu, L., Yan, J., Zhen, Z.-J., Ji, Y., Liu, C.-Q., Lau, W. Y., Zheng, L., & Xu, J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0247-1 · Cited by 104
Herbold, W., Maus, R., Hahn, I., Ding, N., Srivastava, M., Christman, J. W., Mack, M., Reutershan, J., Briles, D. E., Paton, J. C., et al. (2010) · Infection and Immunity · doi:10.1128/iai.01169-09 · Cited by 103
Ina, K., Kusugami, K., Yamaguchi, T., Imada, A., Hosokawa, T., Ohsuga, M., Shinoda, M., Ando, T., Ito, K., & Yokoyama, Y. (1997) · PubMed · Cited by 103
Johnston, R. A., Mizgerd, J. P., & Shore, S. A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00101.2004 · Cited by 102
Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor
Halpern, J. L., Kilbarger, A. K., & Lynch, C. C. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.04.018 · Cited by 102
Chapter 5 Expression of Chemokines and Chemokine Receptors in Human Colon Cancer
Erreni, M., Bianchi, P. P., Laghi, L., Mirolo, M., Fabbri, M., Locati, M., Mantovani, A., & Allavena, P. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05205-7 · Cited by 101
Is Alveolar Destruction and Emphysema in Chronic Obstructive Pulmonary Disease an Immune Disease?
Taraseviciene-Stewart, L., Douglas, I. S., Nana-Sinkam, P. S., Lee, J. D., Tuder, R. M., Nicolls, M. R., & Voelkel, N. F. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-105sf · Cited by 101
Design of Noncompetitive Interleukin-8 Inhibitors Acting on CXCR1 and CXCR2
Moriconi, A., Cesta, M. C., Cervellera, M. N., Aramini, A., Coniglio, S., Colagioia, S., Beccari, A. R., Bizzarri, C., Cavicchia, M. R., Locati, M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061469t · Cited by 100
Wilson, C., Wilson, T. R., Johnston, P. G., Longley, D. B., & Waugh, D. J. J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0148 · Cited by 100
Discrete Steps in Binding and Signaling of Interleukin-8 with Its Receptor
Wu, L., Ruffing, N., Shi, X., Newman, W., Soler, D. F., Mackay, C. R., & Qin, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31202 · Cited by 99
Growth-Regulated Oncogene Is Pivotal in Thrombin-Induced Angiogenesis
Caunt, M., Hu, L., Tang, T., Brooks, P. C., Ibrahim, S., & Karpatkin, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2570 · Cited by 95
Pharmacological Characterization of AZD5069, a Slowly Reversible CXC Chemokine Receptor 2 Antagonist
Nicholls, D., Wiley, K. E., Dainty, I. A., MacIntosh, F., Phillips, C., Gaw, A. J., & Mårdh, C. K. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221358 · Cited by 95
Altered CXCR2 Signaling in β-Arrestin-2-Deficient Mouse Models
Su, Y., Raghuwanshi, S. K., Yu, Y., Nanney, L. B., Richardson, R. M., & Richmond, A. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5396 · Cited by 94
Nagarkar, D. R., Wang, Q., Shim, J., Zhao, Y., Tsai, W. C., Lukacs, N. W., Sajjan, U. S., & Hershenson, M. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900298 · Cited by 93
Molecular Imaging of Chemokine Receptor CXCR4
Weiss, I. D., & Jacobson, O. (2013) · Theranostics · doi:10.7150/thno.4835 · Cited by 93
Kirsten, A., Förster, K., Radeczky, E., Linnhoff, A., Bálint, B., Watz, H., Wray, H., Salkeld, L., Cullberg, M., & Larsson, B. S. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.02.001 · Cited by 92
Liu, Y.-J., Guo, D.-W., Tian, L., Shang, D.-S., Zhao, W.-D., Li, B., Fang, W.-G., Zhu, L., & Chen, Y.-H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.024 · Cited by 92
CCR1 Antagonists: What Have We Learned From Clinical Trials
Gladue, R. P., Brown, M. F., & Zwillich, S. H. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791561237 · Cited by 92
Schraufstätter, I. U., Trieu, K., Zhao, M., Rose, D. M., Terkeltaub, R. A., & Burger, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6714 · Cited by 91
Padovani-Claudio, D. A., Liu, L., Ransohoff, R. M., & Miller, R. H. (2006) · Glia · doi:10.1002/glia.20383 · Cited by 91
Matsuo, Y., Campbell, P. M., Brekken, R. A., Sung, B., Ouellette, M. M., Fleming, J. B., Aggarwal, B. B., Der, C. J., & Guha, S. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0577 · Cited by 91
CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
Citro, A., Valle, A., Cantarelli, E., Mercalli, A., Pellegrini, S., Liberati, D., Daffonchio, L., Kastsiuchenka, O., Ruffini, P. A., Battaglia, M., et al. (2014) · Diabetes · doi:10.2337/db14-0443 · Cited by 90
Wu, Y., Wang, S., Farooq, S. M., Castelvetere, M. P., Hou, Y., Gao, J., Navarro, J., Oupický, D., Sun, F., & Li, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315762 · Cited by 90
Blockade of the chemokine receptor CXCR2 ameliorates adjuvant‐induced arthritis in rats
Barsante, M. M., Cunha, T. M., Allegretti, M., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707462 · Cited by 88
Sobolik, T., Su, Y., Wells, S., Ayers, G. D., Cook, R. S., & Richmond, A. J. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-07-0360 · Cited by 88
Rafiee, P., Nelson, V. M., Manley, S., Wellner, M. R., Floer, M., Binion, D. G., & Shaker, R. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90428.2008 · Cited by 87
Hu, M., Wang, C., Li, W., Lu, W., Bai, Z., Qin, D., Yan, Q., Zhu, J., Krueger, B. J., Renne, R., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005171 · Cited by 86
Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer.
Lee, L., Schuerer-Maly, C. C., Lofquist, A. K., van Haaften‐Day, C., Ting, J. P. ‐., White, C. M., Martin, B. K., & Haskill, J. S. (1996) · PubMed · Cited by 85
Interleukin genes and associations with colon and rectal cancer risk and overall survival
Bondurant, K. L., Lundgreen, A., Herrick, J. S., Kadlubar, S. A., Wolff, R. K., & Slattery, M. L. (2012) · International Journal of Cancer · doi:10.1002/ijc.27660 · Cited by 84
Neutrophils in Cystic Fibrosis Display a Distinct Gene Expression Pattern
Adib‐Conquy, M., Pédron, T., Petit-Bertron, A.-F., Tabary, O., Corvol, H., Jacquot, J. P., Clément, A., & Cavaillon, J. (2008) · Molecular Medicine · doi:10.2119/2007-00081.adib-conquy · Cited by 83
Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling
Brandolini, L., Cristiano, L., Fidoamore, A., Pizzol, M. D., Giacomo, E. D., Florio, T. M., Confalone, G., Galante, A., Cinque, B., Benedetti, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6234 · Cited by 83
Singh, S., Wu, S., Varney, M. L., Singh, A. P., & Singh, R. K. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.06.011 · Cited by 83
Ryu, J. K., Cho, T., Choi, H. B., Jantaratnotai, N., & McLarnon, J. G. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0339-z · Cited by 82
Maxwell, P. J., Coulter, J. A., Walker, S. M., McKechnie, M., Neisen, J., McCabe, N., Kennedy, R. D., Salto‐Tellez, M., Albanese, C., & Waugh, D. J. J. (2012) · European Urology · doi:10.1016/j.eururo.2012.08.032 · Cited by 82
Maxwell, P. J., Neisen, J., Messenger, J., & Waugh, D. J. J. (2014) · Oncotarget · doi:10.18632/oncotarget.2052 · Cited by 80
Multiple Signaling Pathways of Human Interleukin-8 Receptor A
Richardson, R. M., Ali, H., Pridgen, B. C., Haribabu, B., & Snyderman, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10690 · Cited by 80
Abdollahi, T., Robertson, N. M., Abdollahi, A., & Litwack, G. (2003) · PubMed · Cited by 80
Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking
Kiri, V. A., Fabbri, L. M., Davis, K. J., & Soriano, J. B. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.07.024 · Cited by 79
A homeostatic function of CXCR2 signalling in articular cartilage
Sherwood, J., Bertrand, J., Nalesso, G., Poulet, B., Pitsillides, A. A., Brandolini, L., Karystinou, A., Bari, C. D., Luyten, F. P., Pitzalis, C., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205546 · Cited by 79
Nonpeptide CXCR2 Antagonist Prevents Neutrophil Accumulation in Hyperoxia-Exposed Newborn Rats
Auten, R. L., Richardson, R. M., White, J. R., Mason, S. N., Vozzelli, M. A., & Whorton, M. H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29305-8 · Cited by 78
Neutrophil recruitment by allergens contribute to allergic sensitization and allergic inflammation
Hosoki, K., Itazawa, T., Boldogh, I. R., & Sur, S. (2015) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000231 · Cited by 78
NAP-2 Secreted by Human NK Cells Can Stimulate Mesenchymal Stem/Stromal Cell Recruitment
Almeida, C. R., Caires, H. R., Vasconcelos, D. P., & Barbosa, M. A. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.012 · Cited by 78
Desurmont, T., Skrypek, N., Duhamel, A., Jonckheere, N., Millet, G., Leteurtre, E., Gosset, P., Duchêne, B., Ramdane, N., Hebbar, M., et al. (2015) · Cancer Science · doi:10.1111/cas.12603 · Cited by 77
Sharif, G. M., Schmidt, M. O., Yi, C., Hu, Z., Haddad, B. R., Glasgow, E. F., Riegel, A. T., & Wellstein, A. (2015) · Oncogene · doi:10.1038/onc.2015.44 · Cited by 77
Jurčević, S., Humfrey, C. D. N., Uddin, M., Warrington, S., LARSSON, B. S., & Keen, C. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12724 · Cited by 76
Bohrer, L. R., & Schwertfeger, K. L. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0275 · Cited by 76
CXCR2 inhibition suppresses acute and chronic pancreatic inflammation
Steele, C. W., Karim, S. A., Foth, M., Rishi, L., Leach, J. D. G., Porter, R. J., Nixon, C., Evans, T. J., Carter, C. R., Nibbs, R. J. B., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4555 · Cited by 75
Bertini, R., Barcelos, L. S., Beccari, A., Cavalieri, B., Moriconi, A., Bizzarri, C., Benedetto, P. D., Giacinto, C. D., Gloaguen, I., Galliera, E., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01566.x · Cited by 75
Evaluation of Potent and Selective Small-Molecule Antagonists for the CXCR2 Chemokine Receptor
Widdowson, K. L., Elliott, J. D., Veber, D. F., Nie, H., Rutledge, M. C., McCleland, B. W., Xiang, J., Jurewicz, A. J., Hertzberg, R., Foley, J. J., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034248l · Cited by 75
Parenty, G., Appelbe, S., & Milligan, G. (2008) · Biochemical Journal · doi:10.1042/bj20071689 · Cited by 75
CXCR2 Is Necessary for the Development and Persistence of Chronic Fungal Asthma in Mice
Schuh, J. M., Blease, K., & Hogaboam, C. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1447 · Cited by 75
Tong, H., Ke, J., Jiang, F., Wang, X., Wang, F., Li, Y., Lu, W., & Wan, X. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.036 · Cited by 75
CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells
Sinclair, A., Park, L., Shah, M., Drotar, M. E., Calaminus, S. D. J., Hopcroft, L. E. M., Kinstrie, R., Guitart, A. V., Dunn, K. M., Abraham, S. A., et al. (2016) · Blood · doi:10.1182/blood-2015-08-661785 · Cited by 75
Hall, D. A., Beresford, I. J. M., Browning, C., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702329 · Cited by 74
Zhao, M., Wimmer, A., Trieu, K., DiScipio, R. G., & Schraufstätter, I. U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405118200 · Cited by 74
Wanninger, J., Neumeier, M., Weigert, J., Bauer, S., Weiß, T. S., Schäffler, A., Krempl, C., Bleyl, C., Aslanidis, C., Schölmerich, J., et al. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90644.2008 · Cited by 73
Cataisson, C., Ohman, R., Patel, G., Pearson, A., Tsien, M. Z., Jay, S., Wright, L. N., Hennings, H., & Yuspa, S. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2490 · Cited by 70
Khan, M. N., Wang, B., Wei, J., Zhang, Y., Li, Q., Luan, X., Cheng, J., Gordon, J., Li, F., & Liu, H. (2015) · Oncotarget · doi:10.18632/oncotarget.4066 · Cited by 70
Liu, Y., Holdbrooks, A. T., Meares, G. P., Buckley, J. A., Benveniste, E. N., & Qin, H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403063 · Cited by 68
LIM and SH3 Protein -1 Modulates CXCR2-Mediated Cell Migration
Raman, D., Sai, J., Neel, N. F., Chew, C. S., & Richmond, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010050 · Cited by 68
Role of the C Terminus of the Interleukin 8 Receptor in Signal Transduction and Internalization
Prado, G. N., Suzuki, H., Wilkinson, N., Cousins, B., & Navarro, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19186 · Cited by 68
Sun, H., Chung, W.-C., Ryu, S.-H., Ju, Z., Tran, H. T., Kim, E. J.-H., Kurie, J. M., & Koo, J. S. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-07-0002 · Cited by 68
Chemokine Signaling Specificity: Essential Role for the N-Terminal Domain of Chemokine Receptors
Prado, G. N., Suetomi, K., Shumate, D., Maxwell, C. A., Ravindran, A., Rajarathnam, K., & Navarro, J. (2007) · Biochemistry · doi:10.1021/bi7004043 · Cited by 67
Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis
Singh, R., Nannuru, K. C., Sharma, B., & Varney, M. L. (2011) · Journal of Carcinogenesis · doi:10.4103/1477-3163.92308 · Cited by 67
Manjavachi, M. N., Quintão, N. L. M., Campos, M. M., Deschamps, I. K., Yunes, R. A., Nunes, R. J., Leal, P. C., & Calixto, J. Β. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2009.01.007 · Cited by 66
IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway
Chan, L., Wang, L., Chiang, F., Lee, K., Kuo, P., & Liang, C. (2016) · Oncotarget · doi:10.18632/oncotarget.11445 · Cited by 66
Li, S., Kendall, S. E., Raices, R. M., Finlay, J. B., Covarrubias, M., Liu, Z., Lowe, G. N., Lin, Y.-H., Teh, Y. H., Leigh, V., et al. (2012) · BMC Biology · doi:10.1186/1741-7007-10-73 · Cited by 65
Feniger-Barish, R., Yron, I., Meshel, T., Matityahu, E., & Ben‐Baruch, A. (2003) · Biochemistry · doi:10.1021/bi026783d · Cited by 65
Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans
Kamalakar, A., Bendre, M. S., Washam, C. L., Fowler, T. W., Carver, A. A., Dilley, J. D., Bracey, J. W., Akel, N. S., Margulies, A. G., Skinner, R. A., et al. (2014) · Bone · doi:10.1016/j.bone.2014.01.015 · Cited by 65
VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis
Neel, N. F., Barzik, M., Raman, D., Sobolik-Delmaire, T., Sai, J., Ham, A. L., Mernaugh, R. L., Gertler, F. B., & Richmond, A. J. (2009) · Journal of Cell Science · doi:10.1242/jcs.039057 · Cited by 65
Dong, Y.-L., Kabir, S. M., Lee, E.-S., & Son, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083789 · Cited by 64
Lin, C., Cheng, H.-W., Ma, H., Wu, C., Hong, C.-Y., & Chen, B.-C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112433 · Cited by 64
Miller, B. E., Mistry, S. J., Smart, K. A., Connolly, P., Carpenter, D. C., Cooray, H., Bloomer, J. C., Tal‐Singer, R., & Lazaar, A. L. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0017-x · Cited by 63
Phosphorylation-independent Association of CXCR2 with the Protein Phosphatase 2A Core Enzyme
Fan, G.-H., Yang, W., Sai, J., & Richmond, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009292200 · Cited by 63
Evaluation of a series of bicyclic CXCR2 antagonists
Walters, I. A. S., Austin, C. A., Austin, R. P., Bonnert, R. V., Cage, P. A., Christie, M. I., Ebden, M. R., Gardiner, S. D., Grahames, C., Hill, S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.039 · Cited by 63
Increase of chemokine levels in sputum precedes exacerbation of acute asthma attacks
Kurashima, K., Mukaida, N., Fujimura, M., Schröder, J., Matsuda, T., & Matsushima, K. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.3.313 · Cited by 63
Interleukin-8 promotes cell migration through integrin αvβ6 upregulation in colorectal cancer
Sun, Q., Sun, F., Wang, B., Liu, S., Niu, W., Liu, E., Peng, C., Wang, J., Gao, H., Liang, B., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.021 · Cited by 62
Paul, T., Schumann, C., Rüdiger, S., Boeck, S. H., Heinemann, V., Kächele, V., Steffens, M., Scholl, C., Hichert, V., Seufferlein, T. T. W., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.04.026 · Cited by 62
Alcorn, M. J., Booth, J. L., Coggeshall, K. M., & Metcalf, J. P. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6450-6459.2001 · Cited by 62
Westra, J., der Meer, B. D., de Boer, P., Leeuwen, M. A. V., van Rijswijk, M. H., & Limburg, P. C. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1204 · Cited by 61
Ryan, B. M., Robles, A. I., McClary, A. C., Haznadar, M., Bowman, E. D., Pine, S. R., Brown, D. W., Ma, K., Shiraishi, K., Kohno, T., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2101 · Cited by 60
Lee, Y.-C., Gajdošik, M. Š., Josić, D., Clifton, J. G., Logothetis, C. J., Yu‐Lee, L., Gallick, G. E., Maity, S. N., & Lin, S.-H. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.039909 · Cited by 60
Hosoki, K., Aguilera-Aguirre, L., Brasier, A. R., Kurosky, A., Boldogh, I. R., & Sur, S. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0044oc · Cited by 59
Small interfering RNA‐mediated CXCR1 or CXCR2 knock‐down inhibits melanoma tumor growth and invasion
Singh, S., Sadanandam, A., Varney, M. L., Nannuru, K. C., & Singh, R. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.24714 · Cited by 59
Min, S. H., Wang, Y., Gonsiorek, W., Anilkumar, G., Kozlowski, J. A., Lundell, D. J., Fine, J. S., & Grant, E. P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.025 · Cited by 59
Gorio, A., Madaschi, L., Zadra, G., Marfia, G., Cavalieri, B., Bertini, R., & Giulio, A. M. D. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123679 · Cited by 59
Boppana, N. B., Devarajan, A., Gopal, K., Barathan, M., AbuBakar, S., Shankar, E. M., Ebrahim, A. S., & Farooq, S. M. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213520110 · Cited by 59
Dabkevičienė, D., Jonušienė, V., Žitkutė, V., Žalytė, E., Grigaitis, P., Kirvelienė, V., & Sasnauskienė, A. (2015) · Medical Oncology · doi:10.1007/s12032-015-0703-y · Cited by 59
Wu, S., Singh, S., Varney, M. L., Kindle, S. A., & Singh, R. K. (2012) · Cancer Medicine · doi:10.1002/cam4.28 · Cited by 58
GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1
Wen, Y., Giardina, S. F., Hamming, D., Greenman, J., Zachariah, E., Bacolod, M. D., Liu, H., Shia, J., Amenta, P. S., Barany, F., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0736 · Cited by 58
Devapatla, B. K., Sharma, A., & Woo, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139237 · Cited by 58
The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects
Todd, C., Salter, B., Murphy, D. M., Watson, R. M., Howie, K. J., Milot, J., Sadeh, J., Boulet, L., O’Byrne, P. M., & Gauvreau, G. M. (2016) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2016.09.005 · Cited by 58
MIF and CXCL12 in Cardiovascular Diseases: Functional Differences and Similarities
van der Vorst, E. P. C., Döring, Y., & Weber, C. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00373 · Cited by 57
CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
Wang, C., Wu, K., Yu, Q., Zhang, S., Gao, Z., Liu, Y., Ni, L., Cheng, Y., Guan, Z., Shi, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33569 · Cited by 57
Impaired healing of nitrogen mustard wounds in CXCR2 null mice
Milatovic, S., Nanney, L. B., Yu, Y., White, J. R., & Richmond, A. (2003) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.2003.11310.x · Cited by 55 · cited 1×
“However, they do exhibit impaired wound healing and angiogenesis, increased susceptibility to pathogens, and decreased pathogen clearance due to reduced neutrophil recruitment [109-117].”
Fuhler, G. M., Knol, G. J., Drayer, A. L., & Vellenga, E. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0504306 · Cited by 55
Catusse, J., Liotard, A., Loillier, B., Pruneau, D., & Paquet, J. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01619-2 · Cited by 55
Nabah, Y. N. A., Losada, M., Estellés, R., Mateo, T., Piqueras, L., López‐Ginés, C., Sarau, H. M., Cortijo, J., Morcillo, E. J., Jose, P. J., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147009 · Cited by 55
Gordon, J., Li, F., Zhang, X., et al. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0805458 · Cited by 55
Cohen-Hillel, E., Yron, I., Meshel, T., Soria, G., Attal, H., & Ben‐Baruch, A. (2006) · Cytokine · doi:10.1016/j.cyto.2005.11.006 · Cited by 54
Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization
Pickens, S. R., Chamberlain, N. D., Volin, M. V., Gonzalez, M. H., Pope, R. M., Mandelin, A. M., Kolls, J. K., & Shahrara, S. (2011) · Angiogenesis · doi:10.1007/s10456-011-9227-z · Cited by 54
Wang, Y., Wang, W., Wang, L., Wang, X., & Xia, J. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01337.x · Cited by 54
Chemokine receptor CXCR2 in dorsal root ganglion contributes to the maintenance of inflammatory pain
Cao, D., Qian, B., Zhang, Z., Gao, Y., & Wu, X. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.09.016 · Cited by 54
Lee, C., Syu, S., Liu, K., Chu, P., Yang, W., Lin, P., & Shieh, W.-Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5640 · Cited by 53
Increased invasion through basement membrane by CXCL7-transfected breast cells
Tang, Z., Yu, M., Miller, F. W., Berk, R. S., Tromp, G., & Kosir, M. A. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2008.08.001 · Cited by 53
Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth
Shen, H., Schuster, R. M., Lu, B., Waltz, S. E., & Lentsch, A. B. (2006) · The Prostate · doi:10.1002/pros.20476 · Cited by 52
ELR-CXC Chemokine Receptor Antagonism Targets Inflammatory Responses at Multiple Levels
Zhao, X., Town, J. R., Li, F., Zhang, X., Cockcroft, D. W., & Gordon, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800551 · Cited by 51
Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature
Zhang, G., Gomes-Giacoia, E., Dai, Y. E., Lawton, A., Miyake, M., Furuya, H., Goodison, S., & Rosser, C. J. (2014) · Diagnostic Pathology · doi:10.1186/s13000-014-0200-1 · Cited by 49
Host Cxcr2-dependent regulation of mammary tumor growth and metastasis
Sharma, B., Nannuru, K. C., Varney, M. L., & Singh, R. K. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9691-0 · Cited by 48
Virtala, R., EKMAN, A., Jansson, L., Westin, U. P., & Cardell, L. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03921.x · Cited by 47
GROα promotes invasion of colorectal cancer cells
Fukui (2010) · Oncology Reports · doi:10.3892/or_00001008 · Cited by 47
Baxter, A., Bennion, C., Bent, J., Boden, K., Brough, S., Cooper, A. E., Kinchin, E. C., Kindon, N. D., McInally, T., Mortimore, M., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00561-4 · Cited by 46
CXCR2-Dependent Endothelial Progenitor Cell Mobilization in Pancreatic Cancer Growth
Li, A., Cheng, X. J., Moro, A., Singh, R. K., Hines, O. J., & Eibl, G. (2011) · Translational Oncology · doi:10.1593/tlo.10184 · Cited by 45
Gonçalves, A. S., & Appelberg, R. (2002) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2002.01097.x · Cited by 45
Chao, J., Chao, J., Taveras, A. G., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.04.016 · Cited by 45
Activation of phospholipase D by interleukin-8 in human neutrophils
Sozzani, S., Agwu, D., Ellenburg, M. D., et al. (1994) · Blood · doi:10.1182/blood.v84.11.3895.bloodjournal84113895 · Cited by 45
Venza, I., Visalli, M., Fortunato, C., Ruggeri, M., Ratone, S., Caffo, M., Caruso, G., Alafaci, C., Tomasello, F. F., Teti, D. V., et al. (2012) · Epigenetics · doi:10.4161/epi.22446 · Cited by 44
Sharma, B., Varney, M. L., Saxena, S., Wu, L., & Singh, R. K. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.12.011 · Cited by 44
CXCR2 signaling regulates KRAS(G12D)-induced autocrine growth of pancreatic cancer
Purohit, A., Varney, M. L., Rachagani, S., Ouellette, M. M., Batra, S. K., & Singh, R. K. (2016) · Oncotarget · doi:10.18632/oncotarget.6906 · Cited by 43
Gresnigt, M. S., Rekiki, A., Raşid, O., Savers, A., Jouvion, G., Dannaoui, É., Parlato, M., Fitting, C., Brock, M., Cavaillon, J., et al. (2016) · Scientific Reports · doi:10.1038/srep26490 · Cited by 43
Tiwari, N., Marudamuthu, A. S., Tsukasaki, Y., Ikebe, M., Fu, J., & Shetty, S. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00290.2015 · Cited by 42
Bruno, M. E. C., Rogier, E. W., Arsenescu, R. I., Flomenhoft, D. R., Kurkjian, C. J., Ellis, G. I., & Kaetzel, C. S. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3700-2 · Cited by 41
Immunotherapies in Alzheimer’s disease: Too much, too little, too late or off-target?
St‐Amour, I., Cicchetti, F., & Calon, F. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1518-9 · Cited by 40
Solution NMR characterization of WT CXCL 8 monomer and dimer binding to CXCR 1 N ‐terminal domain
Joseph, P. R. B., & Rajarathnam, K. (2014) · Protein Science · doi:10.1002/pro.2590 · Cited by 38
Winters, M. P., Crysler, C. S., Subasinghe, N. L., Ryan, D., Leong, L., Zhao, S., Donatelli, R. R., Yurkow, E. J., Mazzulla, M. J., Boczon, L., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.127 · Cited by 38
Jin, Q., Nie, H., McCleland, B. W., Widdowson, K. L., Palovich, M. R., Elliott, J. D., Goodman, R. M., Burman, M., Sarau, H. M., Ward, K. W., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.097 · Cited by 38
Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis
Lane, H. C. (2006) · International Immunology · doi:10.1093/intimm/dxl064 · Cited by 37
ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis
O’Hayer, K., Brady, D. C., & Counter, C. M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp198 · Cited by 37
Maeda, D. Y., Peck, A. M., Schuler, A. D., Quinn, M. T., Kirpotina, L. N., Wicomb, W. N., Fan, G.-H., & Zebala, J. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500827t · Cited by 37
The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients
Wang, Z., Liu, H., Shen, Z., Wang, X., Zhang, H., Qin, J., Xu, J., Sun, Y., & Qin, X. (2015) · BMC Cancer · doi:10.1186/s12885-015-1793-9 · Cited by 35
Herlea‐Pana, O., Yao, L., Heuser‐Baker, J., Wang, Q., Wang, Q., Georgescu, C., Zou, M., & Barlic‐Dicen, J. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv111 · Cited by 35
Zhang, X., Zhao, Y.-F., Zhu, S., Huang, W., Luo, Y., Chen, Q.-Y., Ge, L.-J., Li, R., Wang, J., Sun, M., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150041 · Cited by 35
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice
Sousa, L. F. D. C., Coelho, F. M., Rodrigues, D. H., Campos, A. C., Barcelos, L. S., Teixeira, M. M., Rachid, M. A., & Teixeira, A. L. (2013) · Clinics · doi:10.6061/clinics/2013(03)oa17 · Cited by 34
Mizutani, N., Sae‐Wong, C., Kangsanant, S., Nabe, T., & Yoshino, S. (2015) · Immunology · doi:10.1111/imm.12528 · Cited by 34
Oral, H., Kanzler, I., Tuchscheerer, N., Curaj, A., Simsekyilmaz, S., Sönmez, T. T., Radu, E., Postea, O., Weber, C., Schuh, A., et al. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.04.006 · Cited by 33
Khalili, H., Gong, J., Brenner, H., Austin, T. R., Hutter, C. M., Baba, Y., Baron, J. A., Berndt, S. I., Bezieau, S., Caan, B. J., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv086 · Cited by 33
MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells
Dileepan, M., Sarver, A. E., Sriramarao, P., Panettieri, R. A., Subramanian, S., & Kannan, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150842 · Cited by 33
Hunt, F., Austin, C. A., Austin, R. P., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.080 · Cited by 32
CXCR1andCXCR2haplotypes synergistically modulate cystic fibrosis lung disease
Kormann, M., Hector, A., Marcos, V., Mays, L. E., Kappler, M., Illig, T., Klopp, N., Kunze, S., Carevic, M., Rieber, N. P., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00130011 · Cited by 32
Roles of CXCL5 on migration and invasion of liver cancer cells
Xu, X., Huang, P., Yang, B., Wang, X., & Xia, J. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-193 · Cited by 32
3-Arylamino-2H-1,2,4-benzothiadiazin-5-ol 1,1-dioxides as novel and selective CXCR2 antagonists
Wang, Y., Busch‐Petersen, J., Wang, F., Ma, L., Fu, W., Kerns, J. K., Jin, J. J., Palovich, M. R., Shen, J., Burman, M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.011 · Cited by 32
Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target
Guan, X., Hou, Y., Sun, F., Yang, Z., & Li, C. (2016) · Current Drug Targets · doi:10.2174/1389450117666151209120516 · Cited by 32
Yu, L., Li, S., Ma, L., Li, Y., Zhang, X., Peng, Q., Mo, C., Huang, L., Qin, X. Y., & Liu, Y. (2016) · Scientific Reports · doi:10.1038/srep24558 · Cited by 32
Aul, R., Patel, S., Summerhill, S., Kilty, I., Plumb, J., & Singh, D. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.04.008 · Cited by 31
Kim, H. Y., Choi, J. H., Kang, Y. J., Park, S., Choi, H. C., & Kim, H. S. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.120 · Cited by 31
Gemcitabine-induced CXCL8 expression counteracts its actions by inducing tumor neovascularization
Song, Y. H., Baba, T., Li, Y., Furukawa, K., Tanabe, Y., Matsugo, S., Sasaki, S., & Mukaida, N. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.112 · Cited by 30
Xu, L., Ashkenazi, A., & Chaudhuri, A. (2007) · Angiogenesis · doi:10.1007/s10456-007-9084-y · Cited by 30
Zhou, Y., Li, R.-J., Li, M., Liu, X., Zhu, H., Ju, Z., Miao, X., & Xu, G. (2016) · Molecular Pain · doi:10.1177/1744806916646381 · Cited by 30
Hou, Y., Wu, Y., Farooq, S. M., Guan, X., Wang, S., Liu, Y., Oblak, J. J., Holcomb, J., Jiang, Y., Strieter, R. M., et al. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.12.001 · Cited by 29
Deng, M., Ma, T., Yan, Z., Zettel, K. R., Scott, M. J., Liao, H., Frank, A., Morelli, A. E., Sodhi, C. P., Hackam, D. J., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv562 · Cited by 29
Discovery of Novel CXCR2 Inhibitors Using Ligand-Based Pharmacophore Models
Ha, H., Debnath, B., Odde, S., Bensman, T. J., Ho, H., Beringer, P. M., & Neamati, N. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00181 · Cited by 28
Self-citationTherapeutic Implications of Immunogenic Cell Death in Human Cancer
Palombo, F., Focaccetti, C., & Barnaba, V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00503 · Cited by 28
Fast, hungry and unstable: finding the Achilles’ heel of small-cell lung cancer
Hann, C. L., & Rudin, C. M. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.02.003 · Cited by 28
CXCR2 Blockade Reduces Radical Formation in Hyperoxia-Exposed Newborn Rat Lung
Liao, L., Ning, Q., Li, Y., Wang, W., Wang, A., Wei, W., Liu, X., Auten, R. L., Tanswell, A. K., & Luo, X. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000233058.08200.d6 · Cited by 27
Positron Emission Tomographic Imaging of CXCR4 in Cancer: Challenges and Promises
George, G. P. C., Pisaneschi, F., Nguyen, Q., & Aboagye, E. O. (2015) · Molecular Imaging · doi:10.2310/7290.2014.00041 · Cited by 27
Li, L., Khan, M. N., LI, Q., Chen, X., Wei, J., Wang, B., Cheng, J., Gordon, J., & Li, F. (2014) · Oncology Reports · doi:10.3892/or.2014.3659 · Cited by 26
Regulatory mechanisms of betacellulin in CXCL8 production from lung cancer cells
Shi, L., Wang, L., Wang, B., Creţoiu, S. M., Wang, Q., Wang, X., & Chen, C. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-70 · Cited by 26
CXCR2 MediatesBrucella-Induced Arthritis in Interferon γ–Deficient Mice
Lacey, C. A., Keleher, L. L., Mitchell, W. J., Brown, C. R., & Skyberg, J. A. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw087 · Cited by 26
Jung, J., Kang, K., Kim, J.-H., Hong, S.-C., Park, Y., & Kim, B. (2016) · Stem Cells and Development · doi:10.1089/scd.2015.0395 · Cited by 26
N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors
Nie, H., Widdowson, K. L., Palovich, M. R., Fu, W., Elliott, J. D., Bryan, D. L., Burman, M., Schmidt, D. B., Foley, J. J., Sarau, H. M., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.08.042 · Cited by 25
Wilson, C., Maxwell, P. J., Longley, D. B., Wilson, R. H., Johnston, P. G., & Waugh, D. J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036545 · Cited by 25
The role of CXCR2in systemic neovascularization of the mouse lung
Sánchez, J., Moldobaeva, A., McClintock, J. Y., Jenkins, J., & Wagner, E. M. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00037.2007 · Cited by 24
Han, X., Yan, F., Chen, X., Gerard, C. J., & Boisvert, W. A. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.03.001 · Cited by 24
Kimura, A., Sakurai, T., Koumura, A., et al. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0370 · Cited by 24
Nishi, T., Takeuchi, H., Matsuda, S., et al. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0658-7 · Cited by 24
Bakshi, P., Jin, C., Broutin, P., Berhane, B. T., Reed, J. M., & MULLAN, M. J. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.09.051 · Cited by 22
Liu, H., French, B. A., Nelson, T. J., et al. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.08.002 · Cited by 21
Porter, D. W., Bradley, M. E., Brown, Z., Canova, R., Charlton, S. J., Cox, B. J., Hunt, P. A., Kolarik, D., Lewis, S., O'Connor, D. J., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.074 · Cited by 21
Yang, W., Schraw, W. P., Mueller, S. G., & Richmond, A. J. (1997) · Biochemistry · doi:10.1021/bi971594u · Cited by 21
The CXCR2 Gene Polymorphism Is Associated with Stroke in Patients with Essential Hypertension
Timasheva, Y., Насибуллин, Т. Р., & Mustafina, O. E. (2015) · Cerebrovascular Diseases Extra · doi:10.1159/000441529 · Cited by 21
Cited by
Tumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0053-3 · Cited by 1,260
Cambier, S., Gouwy, M., & Proost, P. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00974-6 · Cited by 591
Interleukin-8: An evolving chemokine
Matsushima, K., Yang, D., & Oppenheim, J. J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155828 · Cited by 520
Motzer, R. J., Robbins, P. B., Powles, T., Albiges, L., Haanen, J. B., Larkin, J., Mu, X. J., Ching, K. A., Uemura, M., Pal, S. K., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1044-8 · Cited by 518
Metadata
- Authors
- Ha, H., Debnath, B., & Neamati, N.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2017
- Volume
- 7
- Issue
- 6
- Pages
- 1543-1588
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2611412386
- Cited by
- 789
- References
- 434
- FWCI
- 19.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.